Exact Mass: 319.1056

Exact Mass Matches: 319.1056

Found 108 metabolites which its exact mass value is equals to given mass value 319.1056, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tetrodotoxin

(1R,5R,6R,7R,9S,11R,12R,13S,14S)-14-(hydroxymethyl)-3-imino-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1(7,11).0(1,6)]tetradecane-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)

A quinazoline alkaloid that is a marine toxin isolated from fish such as puffer fish. It has been shown to exhibit potential neutotoxicity due to its ability to block voltage-gated sodium channels. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Tetrodotoxin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=4368-28-9 (retrieved 2024-09-06) (CAS RN: 4368-28-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

RO19-4603

Ro 19-4603

C15H17N3O3S (319.0991)

Salbutamol 4-O-sulfate

{4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenyl}oxidanesulfonic acid

C13H21NO6S (319.109)

Salbutamol 4-O-sulfate is a metabolite of salbutamol. Salbutamol or albuterol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease. It is marketed as Ventolin among other brand names. Salbutamol was the first selective β2-receptor agonist to be marketed — in 1968. It was first sold by Allen & Hanburys under the brand name Ventolin. The drug was an instant success, and has been used for the treatment of asthma ever since. (Wikipedia)

5,9:7,10a-Dimethano-10aH-[1,3]dioxocino[6,5-d]pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-,(4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-

C11H17N3O8 (319.1016)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D049990 - Membrane Transport Modulators

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

1-(2-Methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl urea hydrochloride

C17H13N5O2 (319.1069)

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline

3-[(3,5-Dimethoxyphenyl)(ethyl)amino]-2-hydroxypropane-1-sulphonic acid

C13H21NO6S (319.109)

(1R,3S)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

(1R*,3S*)-1-(5-hydroxymethylfuran-2-yl)-3-carboxy-6-hydroxy-8-methoxy-1,2,3,4-tetrahydroisoquinoline

C16H17NO6 (319.1056)

2-(3,4-dihydro-2-methoxy-4-oxoquinazolinyl)-1H-indole-3-carboxaldehyde|orirenierine B

C18H13N3O3 (319.0957)

Ala Asp Asp

C11H17N3O8 (319.1016)

Gly Asp Glu

C11H17N3O8 (319.1016)

Gly Glu Asp

C11H17N3O8 (319.1016)

Asp Ala Asp

C11H17N3O8 (319.1016)

Asp Asp Ala

C11H17N3O8 (319.1016)

MMV202458

C17H18NO3Cl (319.0975)

Asp Gly Glu

C11H17N3O8 (319.1016)

Glu Gly Asp

C11H17N3O8 (319.1016)

Glu Asp Gly

C11H17N3O8 (319.1016)

Asp Glu Gly

C11H17N3O8 (319.1016)

Albuterol (Salbutamol-4-O-sulfate)

C13H21NO6S (319.109)

Isoetharine sulfate

C13H21NO6S (319.109)

Dabsyl Hydrazine

C14H17N5O2S (319.1103)

N-BOC-2-(3-TRIFLUOROMETHYLPHENYL)-DL-GLYCINE

C14H16F3NO4 (319.1031)

N-Boc-2-(4-trifluoromethylphenyl)-DL-glycine

C14H16F3NO4 (319.1031)

METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)

boc-l-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)

METHYL 4-(ETHYLCARBAMOYL)-2,3-DIFLUORO-[1,1-BIPHENYL]-3-CARBOXYLATE

C17H15F2NO3 (319.102)

2-[4-[2-nitro-4-(trifluoromethyl)phenyl]piperazino]-1-ethanol

C13H16F3N3O3 (319.1144)

1-Azulenesulfonic acid, 3,8-dimethyl-5-(1-methylethyl)-, sodium salt, hydrate (2:2:1)

C15H20NaO4S (319.098)

2-[2-(4-morpholin-4-ylanilino)-1,3-thiazol-4-yl]acetic acid

C15H17N3O3S (319.0991)

N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-2-naphthalenecarboxamide

C18H13N3O3 (319.0957)

Ro 19-4603

Tert-butyl 5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a]thieno[2,3-f][1,4]diazepine-3-carboxylate

C15H17N3O3S (319.0991)

boc-d-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)

Methanone, [4-(4-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)

C16H18ClN3O2 (319.1087)

(E)-P,P-diphenyl-N-(1-phenylethylidene)phosphinic amide

C20H18NOP (319.1126)

Fenamiphos metabolite

C13H22NO4PS (319.1007)

Methanone, [4-(2-chlorophenyl)-1-piperazinyl](3,5-dimethyl-4-isoxazolyl)-

C16H18ClN3O2 (319.1087)

1-Boc-4-(4-Bromobutyl)piperidine

C14H26BrNO2 (319.1147)

METHYL 2-((ISOPROPOXYCARBONYL)AMINO)-5-METHYL-4-(TRIFLUOROMETHYL)BENZOATE

C14H16F3NO4 (319.1031)

[(1R)-1-(benzyloxycarbonylamino)-2-phenyl-ethyl]phosphinic acid

C16H18NO4P (319.0973)

Ethyl 4-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)-3-oxobutanoate

C16H17NO6 (319.1056)

boc-d-2,4,5-trifluorophe

C14H16F3NO4 (319.1031)

4,4,4-Methanetriyltribenzonitrile

C22H13N3 (319.1109)

3-[3-Acetyl-4-hydroxy-2-(4-methoxy-phenyl)-5-oxo-2,5-dihydro-pyrrol-1-yl]-propionic acid

C16H17NO6 (319.1056)

Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate

C16H17NO6 (319.1056)

(3-Fluoro-4-(((4-methoxybenzyl)oxy)carbamoyl)phenyl)boronic acid

C15H15BFNO5 (319.1027)

boc-l-3,4,5-trifluorophenylalanine

C14H16F3NO4 (319.1031)

Nitrazolam

C17H13N5O2 (319.1069)

Rac albuterol-4-sulfate

C13H21NO6S (319.109)

Glutamyl-aspartyl-glycine

C11H17N3O8 (319.1016)

(11R,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)

N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline

C13H21NO6S (319.109)

(11S,13S)-3-Amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo[7.3.1.17,11.01,6]tetradec-3-en-9-olate

C11H17N3O8 (319.1016)

Mugineate(1-)

C12H19N2O8- (319.1141)

1-[[(1,5-Dimethyl-3-pyrazolyl)-oxomethyl]amino]-3-(2-methoxyphenyl)thiourea

C14H17N5O2S (319.1103)

1-(4-Ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea

C15H17N3O3S (319.0991)

Asp-Gly-Glu

C11H17N3O8 (319.1016)

Asp-Ala-Asp

C11H17N3O8 (319.1016)

Asp-Glu-Gly

C11H17N3O8 (319.1016)

4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid (5-methoxycarbonyl-2-furanyl)methyl ester

C16H17NO6 (319.1056)

N-(1,3-benzodioxol-5-ylmethyl)-4-benzofuro[3,2-d]pyrimidinamine

C18H13N3O3 (319.0957)

Ala-Asp-Asp

C11H17N3O8 (319.1016)

Gly-Asp-Glu

C11H17N3O8 (319.1016)

Gly-Glu-Asp

C11H17N3O8 (319.1016)

Glu-Gly-Asp

C11H17N3O8 (319.1016)

Asp-Asp-Ala

C11H17N3O8 (319.1016)

Aspartyl-glycyl-glutamic acid

C11H17N3O8 (319.1016)

(11S,13S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol

C11H17N3O8 (319.1016)

(2S)-N-(4-chloro-2-methylphenyl)-2-(4-methoxyphenoxy)propanamide

C17H18ClNO3 (319.0975)

SB 334867

1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

C17H13N5O2 (319.1069)

Glu-Asp-Gly

C11H17N3O8 (319.1016)

Ro 67-7476

C17H18FNO2S (319.1042)

Ro 67-7476 is a potent positive allosteric modulator of mGluR1 and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC50 of 60.1 nM[1][2]. Ro 67-7476 is a potent P-ERK1/2 agonist?and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC50=163.3 nM)[3].